You are here

Tradjenta

Can a popular class of diabetes drugs that includes Merck's Januvia help treat COVID-19?

Fierce Biotech

Wed, 04/15/20 - 10:52 am

Boehringer Ingelheim

FDA Approves Eli Lilly's and Boehringer Ingelheim Pharmaceuticals' Triple-Combination Diabetes Drug Trijardy XR

Motley Fool

Tue, 01/28/20 - 12:04 pm

Boehringer Ingelheim

ADA: Lilly, Boehringer's DPP-4 drug Tradjenta ties generic rival in heart safety study

Fierce Pharma

Tue, 06/11/19 - 12:06 pm

Boehringer Ingelheim

Boehringer Ingelheim and Lilly announce the CAROLINA cardiovascular outcome trial of Tradjenta met its primary endpoint of non-inferiority compared with glimepiride

Pharmaceutical Business Review

Fri, 02/15/19 - 10:13 am

Boehringer Ingelheim

type 2 diabetes

clinical trials

Lilly, Boehringer hit heart safety mark with Januvia rival Tradjenta. Is that enough?

Fierce Pharma

Fri, 10/5/18 - 08:51 pm

Boehringer Ingelheim

Boehringer, Lilly diabetes drug Tradjenta succeeds in cardiovascular outcome trial

Pharmaceutical Business Review

Sun, 08/26/18 - 12:00 pm

Boehringer Ingelheim

clinical trials

First Patient Enrolled in New Cardiovascular and Renal Outcomes Trial for TRADJENTA® (linagliptin) Tablets in Type 2 Diabetes

Yahoo/PR Newswire

Wed, 07/31/13 - 09:11 am

type 2 diabetes

Boehringer Ingelheim

Diabetes Drugs Under Scrutiny As FDA Considers Another Study

Pharmalot

Wed, 06/12/13 - 12:40 pm

Bristol-Myers Squibb

Boehringer Ingelheim

Boehringer Ingelheim and Lilly initiate MARLINA clinical trial to evaluate use of Tradjenta® (linagliptin) tablets in patients with type 2 diabetes and albuminuria

Yahoo

Tue, 03/19/13 - 10:43 am

Boehringer Ingelheim

Drugmaker Eli Lilly starts sales this week for combination diabetes treatment Jentadueto

Yahoo/AP

Wed, 03/7/12 - 10:15 am

Boehringer Ingelheim and Lilly's New Type 2 Diabetes Treatment Tradjenta (Linagliptin) Tablets for Adults Now Available in U.S. Pharmacies

Pharma Live

Thu, 06/16/11 - 11:25 am

Boehringer Ingelheim

type 2 diabetes